{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:02:20Z","timestamp":1783630940749,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11274-025-04705-z","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:48:22Z","timestamp":1764226102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical evaluation of repositioned non-antibiotic agents against Staphylococcus aureus: a network meta-analysis of survival outcomes"],"prefix":"10.1007","volume":"41","author":[{"given":"Mohammad","family":"Abavisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khoshrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khayami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-1444","authenticated-orcid":false,"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"4705_CR1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867331666230829141301","author":"M Abavisani","year":"2023","unstructured":"Abavisani M, Hoseinzadeh M, Khayami R, Kodori M, Soleimanpour S, Sahebkar A (2023) Statins, allies against antibiotic resistance? Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867331666230829141301","journal-title":"Curr Med Chem"},{"key":"4705_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.procbio.2024.08.023","volume":"147","author":"M Abavisani","year":"2024","unstructured":"Abavisani M, Faraji S, Ansari B, Ebadpour N, Kesharwani P, Sahebkar A (2024a) Exploring the evolutionary links: innate immunity in bacteria and eukaryotes. Process Biochem 147:240\u2013256. https:\/\/doi.org\/10.1016\/j.procbio.2024.08.023","journal-title":"Process Biochem"},{"key":"4705_CR3","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.crbiot.2024.100211","volume":"7","author":"M Abavisani","year":"2024","unstructured":"Abavisani M, Khoshrou A, Foroushan SK, Ebadpour N, Sahebkar A (2024b) Deciphering the gut microbiome: the revolution of artificial intelligence in microbiota analysis and intervention. Curr Res Biotechnol 7:100211. https:\/\/doi.org\/10.1016\/j.crbiot.2024.100211","journal-title":"Curr Res Biotechnol"},{"key":"4705_CR4","doi-asserted-by":"publisher","first-page":"108621","DOI":"10.1016\/j.biotechadv.2025.108621","volume":"83","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Fazeli E, Ebadpour N, Karav S, Kesharwani P, Sahebkar A (2025a) The road less traveled: unexplored targets in the quest for antibiotics against Pseudomonas aeruginosa. Biotechnol Adv 83:108621. https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108621","journal-title":"Biotechnol Adv"},{"issue":"3","key":"4705_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/1061186X.2024.2424895","volume":"33","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Khoshrou A, Eshaghian S, Karav S, Sahebkar A (2025b) Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing. J Drug Target 33(3):341\u2013367. https:\/\/doi.org\/10.1080\/1061186X.2024.2424895","journal-title":"J Drug Target"},{"key":"4705_CR6","doi-asserted-by":"publisher","DOI":"10.4103\/ohbl.ohbl_10_24","author":"SS Adeiza","year":"2024","unstructured":"Adeiza SS, Islam MA, Shittu A (2024) Global, regional, and national burdens: an overlapping meta-analysis on Staphylococcus aureus and its drug-resistant strains. One Health Bulletin. https:\/\/doi.org\/10.4103\/ohbl.ohbl_10_24","journal-title":"One Health Bulletin"},{"issue":"1","key":"4705_CR7","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1038\/s41598-025-87534-2","volume":"15","author":"MSM Alqahtani","year":"2025","unstructured":"Alqahtani MSM, Shahin G, Abdelalim ITI, Khalaf SMH (2025) Evaluation of ecological consequences on the global distribution of Staphylococcus aureus Rosenbach 1884 due to climate change, using Maxent modeling. Sci Rep 15(1):11457. https:\/\/doi.org\/10.1038\/s41598-025-87534-2","journal-title":"Sci Rep"},{"key":"4705_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092247","author":"SZ Alshawwa","year":"2023","unstructured":"Alshawwa SZ, El-Masry TA, Nasr M, Kira AY, Alotaibi HF, Sallam AS et al (2023) Celecoxib-loaded cubosomal nanoparticles as a therapeutic approach for Staphylococcus aureus in vivo infection. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms11092247","journal-title":"Microorganisms"},{"key":"4705_CR9","doi-asserted-by":"publisher","unstructured":"Andrews RM, Bollar GE, Giattina AS, Dalecki AG, Wallace JR Jr, Frantz L et al. (2023) Repurposing sunscreen as an antibiotic: zinc-activated avobenzone inhibits methicillin-resistant Staphylococcus aureus. Metallomics 15(9). https:\/\/doi.org\/10.1093\/mtomcs\/mfad049","DOI":"10.1093\/mtomcs\/mfad049"},{"issue":"25","key":"4705_CR10","doi-asserted-by":"publisher","first-page":"26762","DOI":"10.1021\/acsomega.4c00617","volume":"9","author":"N Bano","year":"2024","unstructured":"Bano N, Parveen S, Saeed M, Siddiqui S, Abohassan M, Mir SS (2024) Drug repurposing of selected antibiotics: an emerging approach in cancer drug discovery. ACS Omega 9(25):26762\u201326779. https:\/\/doi.org\/10.1021\/acsomega.4c00617","journal-title":"ACS Omega"},{"issue":"6268","key":"4705_CR11","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"M Baym","year":"2016","unstructured":"Baym M, Stone LK, Kishony R (2016) Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351(6268):aad3292. https:\/\/doi.org\/10.1126\/science.aad3292","journal-title":"Science"},{"issue":"9","key":"4705_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jclinepi.2014.04.008","volume":"67","author":"S Bello","year":"2014","unstructured":"Bello S, Krogsb\u00f8ll LT, Gruber J, Zhao ZJ, Fischer D, Hr\u00f3bjartsson A (2014) Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias. J Clin Epidemiol 67(9):973\u2013983. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.04.008","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"4705_CR13","doi-asserted-by":"publisher","first-page":"e1011875","DOI":"10.1371\/journal.ppat.1011875","volume":"19","author":"L Bernacchia","year":"2023","unstructured":"Bernacchia L, Gupta A, Paris A, Moores AA, Kad NM (2023) Developing novel antimicrobials by combining cancer chemotherapeutics with bacterial DNA repair inhibitors. PLoS Pathog 19(12):e1011875. https:\/\/doi.org\/10.1371\/journal.ppat.1011875","journal-title":"PLoS Pathog"},{"issue":"3","key":"4705_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2471\/blt.20.251751","volume":"98","author":"P Beyer","year":"2020","unstructured":"Beyer P, Paulin S (2020) Priority pathogens and the antibiotic pipeline: an update. Bull World Health Organ 98(3):151. https:\/\/doi.org\/10.2471\/blt.20.251751","journal-title":"Bull World Health Organ"},{"key":"4705_CR15","doi-asserted-by":"publisher","first-page":"960693","DOI":"10.3389\/fmicb.2022.960693","volume":"13","author":"MC Chifiriuc","year":"2022","unstructured":"Chifiriuc MC, Filip R, Constantin M, Pircalabioru GG, Bleotu C, Burlibasa L et al (2022) Common themes in antimicrobial and anticancer drug resistance. Front Microbiol 13:960693. https:\/\/doi.org\/10.3389\/fmicb.2022.960693","journal-title":"Front Microbiol"},{"key":"4705_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040939","author":"E Correa","year":"2025","unstructured":"Correa E, Rend\u00f3n JP, Bedoya-Betancur V, Montoya J, Duque JM, Naranjo TW (2025) Standardization of a preclinical colon cancer model in male and female BALB\/c mice: macroscopic and microscopic characterization from pre-neoplastic to tumoral lesions. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13040939","journal-title":"Biomedicines"},{"issue":"7","key":"4705_CR17","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/1751-7915.14268","volume":"16","author":"EJA Douglas","year":"2023","unstructured":"Douglas EJA, Wulandari SW, Lovell SD, Laabei M (2023) Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infections. Microb Biotechnol 16(7):1456\u20131474. https:\/\/doi.org\/10.1111\/1751-7915.14268","journal-title":"Microb Biotechnol"},{"issue":"9","key":"4705_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/1061186X.2025.2509283","volume":"33","author":"N Ebadpour","year":"2025","unstructured":"Ebadpour N, Abavisani M, Sahebkar A (2025) Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomics. J Drug Target 33(9):1495\u20131510. https:\/\/doi.org\/10.1080\/1061186X.2025.2509283","journal-title":"J Drug Target"},{"issue":"4","key":"4705_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/jac\/dkae051","volume":"79","author":"ZY Fang","year":"2024","unstructured":"Fang ZY, Zhang ZY, Zheng YD, Lei D, Zhuang J, Li N et al (2024) Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR. J Antimicrob Chemother 79(4):903\u2013917. https:\/\/doi.org\/10.1093\/jac\/dkae051","journal-title":"J Antimicrob Chemother"},{"key":"4705_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2024.136674","volume":"422","author":"Y Gan","year":"2025","unstructured":"Gan Y, Long X, Gong Z, Yuan P, Tang Y, Zhong S, Yang Y (2025) A label-free strategy for directdetection of Staphylococcus aureus in complex matrixes based on RCA and aptamer. Sens Actuator B-Chem 422:136674. https:\/\/doi.org\/10.1016\/j.snb.2024.136674","journal-title":"Sens Actuator B-Chem"},{"key":"4705_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuae011","author":"E Habjan","year":"2024","unstructured":"Habjan E, Schouten GK, Speer A, van Ulsen P, Bitter W (2024) Diving into drug-screening: zebrafish embryos as an in vivo platform for antimicrobial drug discovery and assessment. FEMS Microbiol Rev. https:\/\/doi.org\/10.1093\/femsre\/fuae011","journal-title":"FEMS Microbiol Rev"},{"issue":"14","key":"4705_CR22","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1504022112","volume":"112","author":"MB Harbut","year":"2015","unstructured":"Harbut MB, Vilch\u00e8ze C, Luo X, Hensler ME, Guo H, Yang B et al (2015) Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci U S A 112(14):4453\u20134458. https:\/\/doi.org\/10.1073\/pnas.1504022112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4705_CR23","doi-asserted-by":"publisher","first-page":"5298565","DOI":"10.1155\/2023\/5298565","volume":"2023","author":"J Hemmati","year":"2023","unstructured":"Hemmati J, Chegini Z, Arabestani MR (2023) Niosomal-based drug delivery platforms: A promising therapeutic approach to fight staphylococcus aureus drug resistance. J Nanomater 2023(1):5298565. https:\/\/doi.org\/10.1155\/2023\/5298565","journal-title":"J Nanomater"},{"issue":"1","key":"4705_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12896-024-00874-1","volume":"24","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Chiani M, Asghari B, Roshanaei G, Soleimani Asl S, Shafiei M et al (2024) Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections. BMC Biotechnol 24(1):47. https:\/\/doi.org\/10.1186\/s12896-024-00874-1","journal-title":"BMC Biotechnol"},{"key":"4705_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"4705_CR26","doi-asserted-by":"publisher","first-page":"e56485","DOI":"10.15252\/embr.202256485","volume":"24","author":"P Hunter","year":"2023","unstructured":"Hunter P (2023) Replacing mammals in drug development: non-mammalian models accelerate translational and pre-clinical research: Non-mammalian models accelerate translational and pre-clinical research. EMBO Rep 24(1):e56485. https:\/\/doi.org\/10.15252\/embr.202256485","journal-title":"EMBO Rep"},{"issue":"6","key":"4705_CR27","doi-asserted-by":"publisher","first-page":"e3002667","DOI":"10.1371\/journal.pbio.3002667","volume":"22","author":"BV Ineichen","year":"2024","unstructured":"Ineichen BV, Furrer E, Gr\u00fcninger SL, Z\u00fcrrer WE, Macleod MR (2024) Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications. PLoS Biol 22(6):e3002667. https:\/\/doi.org\/10.1371\/journal.pbio.3002667","journal-title":"PLoS Biol"},{"issue":"6","key":"4705_CR28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/cid\/ciz323","volume":"70","author":"KA Jackson","year":"2020","unstructured":"Jackson KA, Gokhale RH, Nadle J, Ray SM, Dumyati G, Schaffner W et al (2020) Public health importance of invasive methicillin-sensitive Staphylococcus aureus infections: surveillance in 8 US counties, 2016. Clin Infect Dis 70(6):1021\u20131028. https:\/\/doi.org\/10.1093\/cid\/ciz323","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4705_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1566524020666200619125404","volume":"21","author":"P Jain","year":"2021","unstructured":"Jain P, Jain SK, Jain M (2021) Harnessing drug repurposing for exploration of new diseases: an insight to strategies and case studies. Curr Mol Med 21(2):111\u2013132. https:\/\/doi.org\/10.2174\/1566524020666200619125404","journal-title":"Curr Mol Med"},{"key":"4705_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1182\/blood-2019-128781","volume":"134","author":"C Ju","year":"2019","unstructured":"Ju C, Zhang M, Jia D, Tang J, Li S, Zhao J et al (2019) BALB\/c-hCD3E transgenic mice: an ideal animal model for in vivo efficacy study of CD3-bispecific antibodies. Blood 134:1048. https:\/\/doi.org\/10.1182\/blood-2019-128781","journal-title":"Blood"},{"issue":"10","key":"4705_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00044-022-02960-5","volume":"31","author":"M Kaul","year":"2022","unstructured":"Kaul M, Ferrer-Gonz\u00e1lez E, Mark L, Parhi AK, LaVoie EJ, Pilch DS (2022) Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant Staphylococcus aureus. Med Chem Res 31(10):1705\u20131715. https:\/\/doi.org\/10.1007\/s00044-022-02960-5","journal-title":"Med Chem Res"},{"key":"4705_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051169","author":"MT Khayat","year":"2022","unstructured":"Khayat MT, Abbas HA, Ibrahim TS, Khayyat AN, Alharbi M, Darwish KM et al (2022) Anti-quorum sensing activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10051169","journal-title":"Biomedicines"},{"key":"4705_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01140-20","author":"W Kim","year":"2020","unstructured":"Kim W, Zou G, Pan W, Fricke N, Faizi HA, Kim SM et al (2020) The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus. Mbio. https:\/\/doi.org\/10.1128\/mBio.01140-20","journal-title":"Mbio"},{"key":"4705_CR34","doi-asserted-by":"publisher","unstructured":"Kumar H, Mishra G, Sharma AK, Gothwal A, Kesharwani P, Gupta U. Intranasal drug delivery: A non-invasive approach for the better delivery of neurotherapeutics. Pharmaceutical Nanotechnology, Volume 5, Number 3, 2017, pp. 203\u2013214(12). https:\/\/doi.org\/10.2174\/2211738505666170515113936","DOI":"10.2174\/2211738505666170515113936"},{"issue":"1","key":"4705_CR35","doi-asserted-by":"publisher","first-page":"e03469","DOI":"10.1128\/spectrum.03469-22","volume":"11","author":"J Li","year":"2022","unstructured":"Li J, Zhang X, Han N, Wan P, Zhao F, Xu T et al (2022) Mechanism of action of isopropoxy benzene guanidine against multidrug-resistant pathogens. Microbiology Spectrum 11(1):e03469-e3522. https:\/\/doi.org\/10.1128\/spectrum.03469-22","journal-title":"Microbiology Spectrum"},{"issue":"11","key":"4705_CR36","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","volume":"19","author":"G Liu","year":"2023","unstructured":"Liu G, Catacutan DB, Rathod K, Swanson K, Jin W, Mohammed JC et al (2023) Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat Chem Biol 19(11):1342\u20131350. https:\/\/doi.org\/10.1038\/s41589-023-01349-8","journal-title":"Nat Chem Biol"},{"issue":"1","key":"4705_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40779-024-00510-1","volume":"11","author":"G-Y Liu","year":"2024","unstructured":"Liu G-Y, Yu D, Fan M-M, Zhang X, Jin Z-Y, Tang C et al (2024) Antimicrobial resistance crisis: could artificial intelligence be the solution? Mil Med Res 11(1):7. https:\/\/doi.org\/10.1186\/s40779-024-00510-1","journal-title":"Mil Med Res"},{"issue":"2","key":"4705_CR38","doi-asserted-by":"publisher","first-page":"e03201","DOI":"10.1128\/spectrum.03201-23","volume":"12","author":"T Maydaniuk Dustin","year":"2024","unstructured":"Maydaniuk Dustin T, Martens B, Iqbal S, Hogan Andrew M, LorenteCobo N, Motnenko A et al (2024) The mechanism of action of auranofin analogs in B. cenocepacia revealed by chemogenomic profiling. Microbiol Spectrum 12(2):e03201-23. https:\/\/doi.org\/10.1128\/spectrum.03201-23","journal-title":"Microbiol Spectrum"},{"key":"4705_CR39","doi-asserted-by":"publisher","first-page":"xtac014","DOI":"10.1093\/femsmc\/xtac014","volume":"3","author":"A Miyashita","year":"2022","unstructured":"Miyashita A, Mitsutomi S, Mizushima T, Sekimizu K (2022) Repurposing the PDMA-approved drugs in Japan using an insect model of staphylococcal infection. FEMS Microbes 3:xtac014. https:\/\/doi.org\/10.1093\/femsmc\/xtac014","journal-title":"FEMS Microbes"},{"issue":"1","key":"4705_CR40","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1038\/s41598-024-55773-4","volume":"14","author":"A Morimura","year":"2024","unstructured":"Morimura A, Taniguchi M, Takei H, Sakamoto O, Naono N, Akeda Y, Onozuka D, Yoshimura J, Tomono K, Kutsuna S, Hamaguchi S (2024) Using novel micropore technology combined with artificial intelligence to differentiate Staphylococcus aureus and Staphylococcus epidermidis. Sci Rep 14(1):6994. https:\/\/doi.org\/10.1038\/s41598-024-55773-4","journal-title":"Sci Rep"},{"issue":"27","key":"4705_CR41","doi-asserted-by":"publisher","first-page":"10414","DOI":"10.1073\/pnas.0604055103","volume":"103","author":"TI Moy","year":"2006","unstructured":"Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM (2006) Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A 103(27):10414\u201310419. https:\/\/doi.org\/10.1073\/pnas.0604055103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4705_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","volume":"38","author":"P Mukherjee","year":"2022","unstructured":"Mukherjee P, Roy S, Ghosh D, Nandi SK (2022) Role of animal models in biomedical research: a review. Lab Anim Res 38(1):18. https:\/\/doi.org\/10.1186\/s42826-022-00128-1","journal-title":"Lab Anim Res"},{"issue":"Supplement_1","key":"4705_CR43","doi-asserted-by":"publisher","first-page":"ofae6311014","DOI":"10.1093\/ofid\/ofae631.1014","volume":"12","author":"S Naguthevar","year":"2025","unstructured":"Naguthevar S, Kaur N, Neetha TR, Khatod Y, Kanagiri T, Kumar B et al (2025) P-822. Unraveling the landscape of staphylococcus aureus bloodstream infection: insights from a single-center study. Open Forum Infectious Diseas 12(Supplement_1):ofae6311014. https:\/\/doi.org\/10.1093\/ofid\/ofae631.1014","journal-title":"Open Forum Infectious Diseas"},{"key":"4705_CR44","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"10","key":"4705_CR45","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","volume":"17","author":"WCV Soo","year":"2017","unstructured":"Soo WCV, Kwan BW, Quezada H, Castillo-Ju\u00e1rez I, P\u00e9rez-Eretza B, Julieta Garc\u00eda-Contreras S et al (2017) Repurposing of anticancer drugs for the treatment of bacterial infections. Curr Topics Med Chem 17(10):1157\u20131176. https:\/\/doi.org\/10.2174\/1568026616666160930131737","journal-title":"Curr Topics Med Chem"},{"issue":"7","key":"4705_CR46","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1039\/C9TB02628B","volume":"8","author":"P Srivastava","year":"2020","unstructured":"Srivastava P, Hira SK, Paladhi A, Singh R, Gupta U, Srivastava DN et al (2020) Studies on interaction potency model based on drug synergy and therapeutic potential of triple stimuli-responsive delivery of doxorubicin and 5-fluoro-2-deoxyuridine against lymphoma using disulfide-bridged cysteine over mesoporous silica nanoparticles. J Mater Chem B 8(7):1411\u20131421. https:\/\/doi.org\/10.1039\/C9TB02628B","journal-title":"J Mater Chem B"},{"issue":"5","key":"4705_CR47","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1021\/acs.molpharmaceut.1c00050","volume":"18","author":"P Srivastava","year":"2021","unstructured":"Srivastava P, Paladhi A, Singh R, Srivastava DN, Singh RA, Hira SK et al (2021) Targeting PD-1 in CD8+ T cells with a biomimetic bilirubin-5-fluoro-2-deoxyuridine\u2013bovine serum albumin nanoconstruct for effective chemotherapy against experimental lymphoma. Mol Pharm 18(5):2053\u20132065. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00050","journal-title":"Mol Pharm"},{"key":"4705_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd6737","author":"J Sun","year":"2021","unstructured":"Sun J, Uchiyama S, Olson J, Morodomi Y, Cornax I, Ando N et al (2021) Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abd6737","journal-title":"Sci Transl Med"},{"issue":"3","key":"4705_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318\u2013327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"key":"4705_CR50","doi-asserted-by":"publisher","first-page":"22571","DOI":"10.1038\/srep22571","volume":"6","author":"S Thangamani","year":"2016","unstructured":"Thangamani S, Mohammad H, Abushahba MF, Sobreira TJ, Hedrick VE, Paul LN et al (2016) Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Sci Rep 6:22571. https:\/\/doi.org\/10.1038\/srep22571","journal-title":"Sci Rep"},{"issue":"12","key":"4705_CR51","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4155\/fmc-2018-0544","volume":"11","author":"N Tharmalingam","year":"2019","unstructured":"Tharmalingam N, Ribeiro NQ, da Silva DL, Naik MT, Cruz LI, Kim W et al (2019) Auranofin is an effective agent against clinical isolates of Staphylococcus aureus. Future Med Chem 11(12):1417\u20131425. https:\/\/doi.org\/10.4155\/fmc-2018-0544","journal-title":"Future Med Chem"},{"issue":"4","key":"4705_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12161-008-9056-x","volume":"2","author":"T Trn\u010d\u00edkov\u00e1","year":"2009","unstructured":"Trn\u010d\u00edkov\u00e1 T, Hru\u0161\u0161kov\u00e1\u00e1 V, Oravcov\u00e1\u00e1 K, Pangallo D, Kacl\u00ed\u00edkov\u00e1\u00e1 E (2009) Rapid and Sensitive Detection of Staphylococcus aureus inFood Using Selective Enrichment and Real-Time PCR Targeting a New Gene Marker. Food Anal Methods 2(4):241\u2013250. https:\/\/doi.org\/10.1007\/s12161-008-9056-x","journal-title":"Food Anal Methods"},{"key":"4705_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/polym14153118","author":"H Umar","year":"2022","unstructured":"Umar H, Wahab HA, Gazzali AM, Tahir H, Ahmad W (2022) Cubosomes: design, development, and tumor-targeted drug delivery applications. Polymers. https:\/\/doi.org\/10.3390\/polym14153118","journal-title":"Polymers"},{"issue":"9","key":"4705_CR54","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1038\/s41396-021-00945-7","volume":"15","author":"Y Wang","year":"2021","unstructured":"Wang Y, Lu J, Zhang S, Li J, Mao L, Yuan Z et al (2021) Non-antibiotic pharmaceuticals promote the transmission of multidrug resistance plasmids through intra- and intergenera conjugation. ISME J 15(9):2493\u20132508. https:\/\/doi.org\/10.1038\/s41396-021-00945-7","journal-title":"ISME J"},{"issue":"5","key":"4705_CR55","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1021\/acsinfecdis.3c00611","volume":"10","author":"C Wang","year":"2024","unstructured":"Wang C, Ji Y, Huo X, Li X, Lu W, Zhang Z et al (2024) Discovery of salifungin as a repurposed antibiotic against methicillin-resistant Staphylococcus aureus with limited resistance development. ACS Infect Dis 10(5):1576\u20131589. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00611","journal-title":"ACS Infect Dis"},{"issue":"1","key":"4705_CR56","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/wnl.0000000000007718","volume":"93","author":"R Watzlawick","year":"2019","unstructured":"Watzlawick R, Antonic A, Sena ES, Kopp MA, Rind J, Dirnagl U et al (2019) Outcome heterogeneity and bias in acute experimental spinal cord injury: a meta-analysis. Neurology 93(1):e40\u2013e51. https:\/\/doi.org\/10.1212\/wnl.0000000000007718","journal-title":"Neurology"},{"issue":"1","key":"4705_CR57","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s42003-022-03561-z","volume":"5","author":"C Xu","year":"2022","unstructured":"Xu C, Liu C, Chen K, Zeng P, Chan EWC, Chen S (2022) Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters. Commun Biol 5(1):613. https:\/\/doi.org\/10.1038\/s42003-022-03561-z","journal-title":"Commun Biol"},{"issue":"11","key":"4705_CR58","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4155\/fmc-2021-0030","volume":"13","author":"B Yang","year":"2021","unstructured":"Yang B, Mei Y, Li Q, Zhang M, Tang H, Liu T et al (2021) Repurposing celecoxib analogues as leads for antibiotics. Future Med Chem 13(11):959\u2013974. https:\/\/doi.org\/10.4155\/fmc-2021-0030","journal-title":"Future Med Chem"},{"issue":"28","key":"4705_CR59","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","volume":"21","author":"W Younis","year":"2015","unstructured":"Younis W, Thangamani S, Seleem MN (2015) Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections. Curr Pharm des 21(28):4106\u20134111. https:\/\/doi.org\/10.2174\/1381612821666150506154434","journal-title":"Curr Pharm des"},{"issue":"6","key":"4705_CR60","doi-asserted-by":"publisher","first-page":"e0031724","DOI":"10.1128\/msphere.00317-24","volume":"9","author":"L Yuan","year":"2024","unstructured":"Yuan L, Xi H, Luo Z, Liu MF, Chen Q, Zhu Q et al (2024) Exploring the potential of isorhapontigenin: attenuating Staphylococcus aureus virulence through MgrA-mediated regulation. mSphere 9(6):e0031724. https:\/\/doi.org\/10.1128\/msphere.00317-24","journal-title":"mSphere"},{"key":"4705_CR61","doi-asserted-by":"publisher","first-page":"633467","DOI":"10.3389\/fmicb.2021.633467","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Xiong W, Peng X, Lu Y, Hao J, Qin Z et al (2021) Isopropoxy benzene guanidine kills Staphylococcus aureus without detectable resistance. Front Microbiol 12:633467. https:\/\/doi.org\/10.3389\/fmicb.2021.633467","journal-title":"Front Microbiol"},{"key":"4705_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116621","volume":"255","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu X, Luo J, Liu H, Li Y, Liu J, Zhu L, Zeng H (2025) Dual recombinase polymerase amplification system combined with lateral flow immunoassay for simultaneous detection of Staphylococcus aureus and Vibrio parahaemolyticus. J Pharm Biomed Anal 255:116621. https:\/\/doi.org\/10.1016\/j.jpba.2024.116621","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4705_CR63","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1038\/s41598-020-60825-6","volume":"10","author":"X Zhen","year":"2020","unstructured":"Zhen X, Lundborg CS, Zhang M, Sun X, Li Y, Hu X et al (2020) Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China. Sci Rep 10(1):3900. https:\/\/doi.org\/10.1038\/s41598-020-60825-6","journal-title":"Sci Rep"},{"issue":"3","key":"4705_CR64","doi-asserted-by":"publisher","first-page":"e0088422","DOI":"10.1128\/spectrum.00884-22","volume":"10","author":"YD Zheng","year":"2022","unstructured":"Zheng YD, Zhong T, Wu H, Li N, Fang Z, Cao L et al (2022) Crizotinib shows antibacterial activity against gram-positive bacteria by reducing ATP production and targeting the CTP synthase PyrG. Microbiol Spectr 10(3):e0088422. https:\/\/doi.org\/10.1128\/spectrum.00884-22","journal-title":"Microbiol Spectr"},{"key":"4705_CR65","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3389\/fmicb.2020.01720","volume":"11","author":"L Zhou","year":"2020","unstructured":"Zhou L, She P, Tan F, Li S, Zeng X, Chen L et al (2020) Repurposing antispasmodic agent otilonium bromide for treatment of Staphylococcus aureus infections. Front Microbiol 11:1720. https:\/\/doi.org\/10.3389\/fmicb.2020.01720","journal-title":"Front Microbiol"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-025-04705-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-025-04705-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-025-04705-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T04:29:59Z","timestamp":1767673799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-025-04705-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4705"],"URL":"https:\/\/doi.org\/10.1007\/s11274-025-04705-z","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}